Display options
Filter resources
Text Availability
Article type
Publication date
Showing 1 to 12 of 954 entries
Sorted by: Best Match Show Resources per page
The significance of complement on the red cell surface.

Freedman J.
PMID: 2980267
Transfus Med Rev. 1987 Apr;1(1):58-70. doi: 10.1016/s0887-7963(87)70006-6.

No abstract available.

Management of beta-thalassemia major using transfusions and iron chelation with deferoxamine.

Freedman MH.
PMID: 2980085
Transfus Med Rev. 1988 Sep;2(3):161-75. doi: 10.1016/s0887-7963(88)70041-3.

No abstract available.

The immunogenicity of platelet membrane glycoproteins.

Kunicki TJ, Furihata K, Bull B, Nugent DJ.
PMID: 2980263
Transfus Med Rev. 1987 Apr;1(1):21-33. doi: 10.1016/s0887-7963(87)70003-0.

No abstract available.

Recent developments in the Kell blood group system.

Marsh WL, Redman CM.
PMID: 2980265
Transfus Med Rev. 1987 Apr;1(1):4-20. doi: 10.1016/s0887-7963(87)70002-9.

No abstract available.

Transfusion associated AIDS.

Berkman SA, Groopman JE.
PMID: 2980077
Transfus Med Rev. 1988 Mar;2(1):18-28. doi: 10.1016/s0887-7963(88)70028-0.

No abstract available.

Clinical use of blood transfusion devices.

Ciavarella D, Snyder E.
PMID: 2980083
Transfus Med Rev. 1988 Jun;2(2):95-111. doi: 10.1016/s0887-7963(88)70036-x.

No abstract available.

The uses of radiolabeled red cells in transfusion medicine.

Davey RJ.
PMID: 2980084
Transfus Med Rev. 1988 Sep;2(3):151-60. doi: 10.1016/s0887-7963(88)70040-1.

The ability to radiolabel and follow the red cell in vivo has been of great value to the clinician and the investigator. An understanding of the advantages and disadvantages of the three nuclides used in transfusion medicine--51Cr, 99mTc, and...

Transfusion-associated hepatitis B: past and present.

Seeff LB.
PMID: 2980089
Transfus Med Rev. 1988 Dec;2(4):204-14. doi: 10.1016/s0887-7963(88)70046-2.

Thus, it can be concluded that: (1) Hepatitis B, even before the introduction of donor screening for HBsAg, probably never accounted for more than one-quarter of all cases of transfusion-associated hepatitis. (2) As of 1988, the frequency of this...

Indications for the use of cytomegalovirus-seronegative blood products.

Preiksaitis JK.
PMID: 1666324
Transfus Med Rev. 1991 Jan;5(1):1-17. doi: 10.1016/s0887-7963(91)70189-2.

No abstract available.

Human retroviruses: a common virology.

Kaplan M.
PMID: 2520546
Transfus Med Rev. 1989 Jan;3(1):4-8. doi: 10.1016/s0887-7963(89)70228-5.

There are five known human retroviruses: human T-lymphotropic virus-I (HTLV-I), HTLV-II, HTLV-V, human immunodeficiency virus-1 (HIV-1), and HIV-2. These are related to animal lentiviruses. The simian retroviruses, simian T-lymphotropic virus-I (STLV-I) and STLV-III are related closely to HTLV-I and...

High-titer, low-avidity (HTLA) antibodies and antigens: a review.

Rolih SD.
PMID: 2520549
Transfus Med Rev. 1989 Apr;3(2):128-39. doi: 10.1016/s0887-7963(89)70074-2.

Antibodies that react to HTLA characteristics cause difficulties in serologic testing because of the weak reactions they produce in the indirect antiglobulin test. Those specificities that are more frequently encountered (anti-Yka, -McCa, -Kna, -Ch) are directed toward antigens of...

Use of intravenous gammaglobulin as an immune replacement and an immune suppressant.

Boshkov LK, Kelton JG.
PMID: 2520551
Transfus Med Rev. 1989 Apr;3(2):82-120. doi: 10.1016/s0887-7963(89)70072-9.

No abstract available.

Showing 1 to 12 of 954 entries